You are here: Home » Opinion » Chinese
Business Standard

The drug mantra

Business Standard  |  New Delhi 

The whole world may be excited and applauding India’s move to allow compulsory licensing on expensive anti-cancer drugs, bringing down their prices significantly, but those in government considering more such approvals already appear to be bored with the whole issue. Discussing three more drugs under consideration for compulsory licensing, an official in the Department of Industrial Policy and Promotion said, “I am quite bored of talking about compulsory licensing now. I feel like a priest at a wedding ceremony chanting the same mantras again and again.” It is for the companies to feel excited about it, he added, and not the government.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, March 28 2013. 21:05 IST